Shares of Ozempic-maker Novo Nordisk were down more than 20% in recent trade as the Danish drugmaker headed for its worst day since the 1980s. The stock took a hit after a late-stage trial showed that ...

Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.

The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $ ...

Novo Nordisk has plenty of avenues to pursue for growth. However, its competitive environment will soon become more challenging. Its valuation may also become a bit less favorable. But with such ...

Novo Nordisk's stock declined 22% over the past six months, influenced by competitive pressures and supply constraints. Eli Lilly's Zepbound is rapidly gaining market share, challenging Novo's ...

Biden proposes expanding coverage for anti-obesity drugs Novo shares jump as much as 4.9%, Lilly stock also gains Amgen weight-loss drug trial results miss market expectations Nov 26 (Reuters ...

This story is one of many that illustrate part of what made Jobs and his leadership at Apple so effective: Steve Jobs followed the 10-80-10 rule. The 10-80-10 rule is a leadership principle that ...

NEW LENOX, Ill. (CBS) -- A person was shot and later died Monday evening on Interstate 80 in New Lenox. Illinois State Police were called to the I-80 westbound entrance to I-355 at 5:30 p.m. They ...

Several existing investors—including RA Capital Management and Novo Holdings—also participated in the round. Adcendo will use the funds to develop and expand its early-stage ADC programs ...

Novo Nordisk’s (NVO) (OTCPK:NONOF) contract with Swiss medical device maker Ypsomed (OTCPK:YPHDF) includes a deal to supply injection pens for Danish drugmaker’s next-gen obesity therapy ...

Novo Nordisk NVO shares have lost 25.1% in the past three months compared with the industry’s decline of 17.7%. The company has also underperformed the sector and the S&P 500 during the same ...